Details for New Drug Application (NDA): 076829
✉ Email this page to a colleague
NDA 076829 describes AMMONIUM LACTATE, which is a drug marketed by Padagis Israel, Taro, and Watson Labs Inc, and is included in six NDAs. It is available from five suppliers. Additional details are available on the AMMONIUM LACTATE profile page.
The generic ingredient in AMMONIUM LACTATE is ammonium lactate. There are forty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ammonium lactate profile page.
The generic ingredient in AMMONIUM LACTATE is ammonium lactate. There are forty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ammonium lactate profile page.
Summary for 076829
| Tradename: | AMMONIUM LACTATE |
| Applicant: | Watson Labs Inc |
| Ingredient: | ammonium lactate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | EQ 12% BASE | ||||
| Approval Date: | Feb 7, 2006 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
